Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2)

Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2)

US Patent 11111304 · Granted Sep 7, 2021

Estimated economic value: $31,357,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fully human antibodies that bind to vascular endothelial growth factor receptor 2024
Fully human antibodies that bind to vascular endothelial growth factor receptor 2024
Fully human antibodies that bind to vascular endothelial growth factor receptor 2024
Fully human antibodies that bind to vascular endothelial growth factor receptor 2024
Antibody therapeutics that bind CD382024
Antibody therapeutics that bind CD382024
Antigen binding proteins that bind PD-L12024
Antigen binding proteins that bind PD-L12024
Antigen binding proteins that bind PD-L12024
Antigen binding proteins that bind PD-L12024
CD-38 directed chimeric antigen receptor constructs2023
Antibody therapeutics that bind CD1232023